David C Hastings has an estimated net worth of $31.1 Million. This is based on reported shares across multiple companies, which include INCYTE CORP, Arbutus Biopharma Corp, Entasis Therapeutics Holdings Inc., SCYNEXIS INC, Unilife Corp, Vascular Biogenics Ltd., and Trevi Therapeutics, Inc..

2014 was David C Hastings's most active year for acquiring shares with 18 total transactions. David C Hastings's most active month to acquire stocks was the month of January. 2014 was David C Hastings's most active year for disposing of shares, totalling 21 transactions. David C Hastings's most active month to dispose stocks was the month of January. 2014 saw David C Hastings paying a total of $5,260,250.00 for 499,829 shares, this is the most they've acquired in one year. In 2014 David C Hastings cashed out on 950,000 shares for a total of $28,659,232.72, their largest year based on trade value.